A prospective phase II clinical study: hypofractionated intensity modulated carbon radiation therapy treat for unresectable chordoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800018046

Enrollment

Unknown

Registered

2018-08-28

Start date

2018-10-30

Completion date

Unknown

Last updated

2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sacral chordoma

Interventions

Case series:carbon ion therapy

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) disease confirmed by pathology, confirmed by surgeon witch is unresectable or patients refuse surgery; 2) age from 14-70 years old;

Exclusion criteria

Exclusion criteria: 1) Regional lymph node metastasis or distant metastasis; 2) patients have abdominal or pelvic radiotherapy history; 3) organ at risk can not achieve safety dose limitation; 4) pregnant or lactating women; 5) With other malignant tumor disease(except skin basal cell carcinoma).

Design outcomes

Primary

Measure	Time frame
local contral rete;	—

Secondary

Measure	Time frame
overall survival;	—

Countries

China

Contacts

Public ContactQing Zhang

Shanghai Proton and Heavy Ion Center

qing.zhang@sphic.org.cn+86 13917374609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026